BRAF and NRAS-mutated melanomas showed a significantly lower incidence of coexisting mutations of different genes (10 and 8.1%, respectively) as compared to PIK3CA, HRAS and KIT-mutated melanomas (75, 67 and 36%; all P < .001). The gene discussed is KIT; the disease is melanoma.